Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?

In this Point/Counterpoint, Drs. Bhat and Punnen argue that active surveillance can be beneficial for patients with intermediate-risk prostate cancer.

Source: CancerNetwork - June 19, 2019 Category: Cancer & Oncology Authors: Abhishek Bhat, MD, Sanoj Punnen, MD, MAS Source Type: news